Cargando…

A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225

Actinium-225 ((225)Ac) is receiving increased attention for its application in targeted radionuclide therapy, due to the short range of its emitted alpha particles in conjunction with their high linear energy transfer, which lead to the eradication of tumor cells while sparing neighboring healthy ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvanou, Evangelia-Alexandra, Stellas, Dimitris, Tsoukalas, Charalampos, Mavroidi, Barbara, Paravatou-Petsotas, Maria, Kalogeropoulos, Nikolaos, Xanthopoulos, Stavros, Denat, Franck, Laurent, Gautier, Bazzi, Rana, Roux, Stephane, Bouziotis, Penelope
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076693/ https://www.ncbi.nlm.nih.gov/pubmed/32098286 http://dx.doi.org/10.3390/pharmaceutics12020188

Ejemplares similares

Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with (68)Ga and (177)Lu as Potential Theranostic Agents
por: Salvanou, Evangelia-Alexandra, et al.
Publicado: (2022)

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging
por: Papadopoulou, Sofia, et al.
Publicado: (2021)

Synthesis and In Vitro Evaluation of Gold Nanoparticles Functionalized with Thiol Ligands for Robust Radiolabeling with (99m)Tc
por: Apostolopoulou, Adamantia, et al.
Publicado: (2021)

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging
por: Tsoukalas, Charalmpos, et al.
Publicado: (2015)

Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study
por: Reissig, Falco, et al.
Publicado: (2021)

Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to Mice
por: Mamai, Maria, et al.
Publicado: (2021)

Synthesis and Stability of Actinium-225 Endohedral Fullerenes, (225)Ac@C(60)
por: Mwakisege, Jofa Gideon, et al.
Publicado: (2020)

Supply and Clinical Application of Actinium-225 and Bismuth-213
por: Morgenstern, Alfred, et al.
Publicado: (2020)

Old Drug, New Delivery Strategy: MMAE Repackaged
por: Lahnif, Hanane, et al.
Publicado: (2023)

An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
por: Morgenstern, Alfred, et al.
Publicado: (2018)

The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
por: Kleynhans, Janke, et al.
Publicado: (2022)

Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review
por: Mdanda, Sipho, et al.
Publicado: (2023)

A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis
por: Tsoukalas, Charalampos, et al.
Publicado: (2018)

Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study
por: Papachristou, Maria, et al.
Publicado: (2018)

In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
por: Meyer, Catherine, et al.
Publicado: (2022)

Evaluation of Actinium-225 Labeled Minigastrin Analogue [(225)Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
por: Qin, Yun, et al.
Publicado: (2020)

Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other Metals
por: Fitzsimmons, Jonathan, et al.
Publicado: (2019)

A Review of 177Lutetium-PSMA and 225Actinium-PSMA as Emerging Theranostic Agents in Prostate Cancer
por: Alam, Mohammad R, et al.
Publicado: (2022)

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
por: Shi, Mengqi, et al.
Publicado: (2022)

Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227
por: Anderson, Peter M., et al.
Publicado: (2022)

Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin
por: Reissig, Falco, et al.
Publicado: (2022)

Daratumumab-(225)Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors
por: Dawicki, Wojciech, et al.
Publicado: (2019)

Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detection
por: Truillet, Charles, et al.
Publicado: (2014)

Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles
por: Żelechowska-Matysiak, Kinga, et al.
Publicado: (2023)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

(225)Actinium-labeled prostate-specific membrane antigen targeting peptide induces complete response in a metastatic prostate cancer patient
por: Aras, Omer, et al.
Publicado: (2021)

Efficacy and Safety of Actinium-225 Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Prostate Cancer: A Systematic Review and Metanalysis
por: Parida, Girish Kumar, et al.
Publicado: (2023)

Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2017)

Alpha Therapy with (225)Actinium Labeled Prostate Specific Membrane Antigen: Reporting New Photopeak of 78 Kilo-electron Volts for Better Image Statistics
por: Rasheed, Rashid, et al.
Publicado: (2019)

Chemistry of the rare radioelements: polonium-actinium
por: Bagnall, Kenneth W
Publicado: (1957)

Synthesis and Characterization of the Actinium Aquo Ion
por: Ferrier, Maryline G., et al.
Publicado: (2017)

Health-Related Quality-of-Life Outcomes with Actinium-225-Prostate-Specific Membrane Antigen-617 Therapy in Patients with Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer
por: Satapathy, Swayamjeet, et al.
Publicado: (2020)

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
por: De Veirman, Kim, et al.
Publicado: (2021)

Spectroscopic and computational investigation of actinium coordination chemistry
por: Ferrier, Maryline G., et al.
Publicado: (2016)

The Actinium Aqua Ion: A Century in the Making
por: Thierer, Laura M., et al.
Publicado: (2017)

Update of Atomic Data for the First Three Spectra of Actinium
por: Kramida, Alexander
Publicado: (2022)

Development of a specific IgY-based ELISA for prothymosin alpha, a bioactive polypeptide with diagnostic and therapeutic potential()
por: Karachaliou, Chrysoula-Evangelia, et al.
Publicado: (2019)

Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies
por: Abou, Diane S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n3cgefgh22ge56m4r86fv20qk